Pluristem Therapeutics Inc. (PSTI) Financials

NASDAQ Currency in USD Disclaimer

$1.00

north_east NA Past Year
Day's range
$0.96
Day's range
$1.04

PSTI Income statement / Annual

Last year (2021), Pluristem Therapeutics Inc.'s total revenue was $0.00, a decrease of 100.00% from the previous year. In 2021, Pluristem Therapeutics Inc.'s net income was -$49.87 M. See Pluristem Therapeutics Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014 FY-2013 FY-2012
Period Ended 06/30/2021 06/30/2020 06/30/2019 06/30/2018 06/30/2017 06/30/2016 06/30/2015 06/30/2014 06/30/2013 06/30/2012
Operating Revenue $0.00 $23,000.00 $54,000.00 $50,000.00 $0.00 $2.85 M $379,000.00 $379,000.00 $679,000.00 $716,000.00
Cost of Revenue $0.00 $0.00 $2,000.00 $2,000.00 $0.00 $100,000.00 $13,000.00 $11,000.00 $20,000.00 $0.00
Gross Profit $0.00 $23,000.00 $52,000.00 $48,000.00 $0.00 $2.75 M $366,000.00 $368,000.00 $659,000.00 $716,000.00
Gross Profit Ratio 0 1 0.96 0.96 0 0.96 0.97 0.97 0.97 1
Research and Development Expenses $30.07 M $21.58 M $26.43 M $22.63 M $21.09 M $19.58 M $19.17 M $19.54 M $17.23 M $9.18 M
General & Administrative Expenses $20.56 M $7.92 M $9.16 M $11.19 M $6.93 M $6.49 M $6.46 M $8.68 M $5.65 M $0.00
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $20.56 M $7.92 M $9.16 M $11.19 M $6.93 M $6.49 M $6.46 M $8.68 M $5.65 M $6.57 M
Other Expenses $0.00 $0.00 $0.00 -$43,000.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $50.62 M $29.50 M $35.58 M $33.78 M $28.02 M $26.07 M $25.63 M $28.22 M $22.88 M $15.75 M
Cost And Expenses $50.62 M $29.50 M $35.59 M $33.78 M $28.02 M $26.17 M $25.65 M $28.23 M $22.90 M $15.75 M
Interest Income $492,000.00 $384,000.00 $385,000.00 $276,000.00 $122,000.00 $149,000.00 $112,000.00 $246,000.00 $266,000.00 $575,000.00
Interest Expense $78,000.00 $196,000.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $29,000.00 $12,000.00
Depreciation & Amortization $1.37 M $1.57 M $1.96 M $2.02 M $2.18 M $2.15 M $2.07 M $1.90 M $1.03 M $435,000.00
EBITDA -$48.42 M -$27.39 M -$33.35 M -$24.11 M -$25.64 M -$21.10 M -$22.60 M -$25.03 M -$20.09 M -$14.35 M
EBITDA Ratio 0 -1190.7 -617.5 -482.16 0 -7.41 -59.64 -66.04 -29.59 -20.04
Operating Income Ratio 0 -1281.57 -658 -674.62 0 -8.19 -66.67 -73.48 -32.73 -20.99
Total Other Income/Expenses Net $758,000.00 $324,000.00 $225,000.00 $7.61 M $205,000.00 $73,000.00 $590,000.00 $918,000.00 $1.07 M $237,000.00
Income Before Tax -$49.87 M -$29.15 M -$35.31 M -$26.13 M -$27.81 M -$23.25 M -$24.68 M -$26.93 M -$21.16 M -$14.79 M
Income Before Tax Ratio 0 -1267.48 -653.83 -522.52 0 -8.17 -65.11 -71.06 -31.16 -20.66
Income Tax Expense $836,000.00 $520,000.00 $225,000.00 $7.61 M $205,000.00 $73,000.00 $590,000.00 $918,000.00 $1.10 M $249,000.00
Net Income -$49.87 M -$29.15 M -$35.31 M -$26.13 M -$27.81 M -$23.25 M -$24.68 M -$26.93 M -$21.16 M -$14.79 M
Net Income Ratio 0 -1267.48 -653.83 -522.52 0 -8.17 -65.11 -71.06 -31.16 -20.66
EPS -1.77 -1.6 -2.86 -2.47 -3.18 -2.92 -3.51 -4.24 -3.81 -3.36
EPS Diluted -1.77 -1.6 -2.86 -2.47 -3.18 -2.92 -3.51 -4.24 -3.81 -3.36
Weighted Average Shares Out $28.11 M $18.20 M $12.33 M $10.59 M $8.74 M $7.95 M $7.03 M $6.35 M $5.55 M $4.40 M
Weighted Average Shares Out Diluted $28.11 M $18.20 M $12.33 M $10.59 M $8.74 M $7.95 M $7.03 M $6.35 M $5.55 M $4.40 M
Link